The Epoch Times remains steadfast in our mission to deliver factual, independent, and insightful reporting to the world. In addition, in 2025, we will work closely with NTD News, our sister media, to bring you ever more exciting live coverage and TV programs.
If you value what we do, the best way to support us is to subscribe. Our Introductory Offer starts as little as $1 a week.
The U.S. Food and Drug Administration (FDA) on Thursday approved a new non-opioid pill, Journavx, for treating moderate-to-severe acute pain in adults, the first drug of its kind to be…
An international operation has brought down the infrastructure of online cybercrime marketplaces that affected millions of American citizens, according to a recent report from the U.S. Department of Justice (DOJ)…
Our mailing address is: The Epoch Times, 229 W 28th St, Fl.5, New York, NY 10001 | Contact Us
*When sharing an article, giftaccess@TheEpochTimes.com is added to the list of recipients. If your friend is not already a subscriber, we will send them a special link for free access to the article.
Epoch Newsroom delivers big stories to your inbox as soon as they break. Manage your email preferences here or unsubscribe from Epoch Newsroom here.
